M1224 HCPCS Level II Code: Intraocular pressure (iop) reduced by a value less than 20% from the pre-intervention level
Medicare Coverage & Payment
- Medicare coverage: Carrier judgment (CMS coverage code C)
- Payment category: Service not separately priced (pricing indicator 00)
- BETOS: Z2
- Effective: January 1, 2024
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Official Registry Overview & Definition
Intraocular pressure (iop) reduced by a value less than 20% from the pre-intervention level is a HCPCS Level II code (M1224) for a Medicare-covered supply, service, or procedure. Short description: Iop dec <20% from base.
Nearest Codes in This Family
Official HCPCS Level II classifications closest to M1224 in its code family, with their registry titles.
- M1219 — Anaphylaxis due to the vaccine on or before the date of the encounter
- M1220 — Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist or artificial intelligence (ai) interpretation documented and reviewed; with evidence of retinopathy
- M1221 — Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist or artificial intelligence (ai) interpretation documented and reviewed; without evidence of retinopathy
- M1222 — Glaucoma plan of care not documented, reason not otherwise specified
- M1223 — Glaucoma plan of care documented
- M1225 — Intraocular pressure (iop) reduced by a value of greater than or equal to 20% from the pre-intervention level
- M1226 — Iop measurement not documented, reason not otherwise specified
- M1227 — Evidence-based therapy was prescribed
- M1228 — Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, has hcv treatment initiated within 3 months of the reactive hcv antibody test
- M1229 — Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, is referred within 1 month of the reactive hcv antibody test to a clinician who treats hcv infection